The epidemiology of inflammatory bowel disease: East meets west

The incidence of inflammatory bowel diseases (IBD) in East has risen over the past decade to become a global disease. The increasing number of studies on the incidence and course of IBD in East has enabled us to explore East versus West differences in the epidemiology of IBD which could enhance our understanding of the heterogeneity of the disease and eventually assist in the discovery of novel therapeutic targets and design of preventive strategies.

[1]  C. Yu,et al.  Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn’s Disease: A Nationwide Population-Based Study , 2019, Digestive Diseases and Sciences.

[2]  S. Bonovas,et al.  Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses. , 2019, Gastroenterology.

[3]  Deng-Chyang Wu,et al.  Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  F. Bendtsen,et al.  A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort. , 2019, Inflammatory bowel diseases.

[5]  H. Yamagami,et al.  The association between environmental factors and the development of Crohn’s disease with focusing on passive smoking: A multicenter case-control study in Japan , 2019, PloS one.

[6]  M. Saruta,et al.  Management of elderly ulcerative colitis in Japan , 2019, Journal of Gastroenterology.

[7]  S. Ng,et al.  Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development. , 2019, The lancet. Gastroenterology & hepatology.

[8]  G. Kaplan,et al.  Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data. , 2019, Gastroenterology.

[9]  S. Ng,et al.  Sex‐based differences in the incidence of inflammatory bowel diseases—pooled analysis of population‐based studies from the Asia‐Pacific region , 2019, Alimentary Pharmacology and Therapeutics.

[10]  S. Ng,et al.  Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific , 2019, The American Journal of Gastroenterology.

[11]  M. Shieh,et al.  Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study , 2018, Intestinal research.

[12]  V. Andersen,et al.  Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study , 2018, Journal of Crohn's & colitis.

[13]  S. Ng,et al.  Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries. , 2018, Gastroenterology.

[14]  M. Dubinsky,et al.  Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort , 2018, Journal of Crohn's & colitis.

[15]  Alexander N. Levy,et al.  Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta‐analysis of Population‐based Studies , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  V. Andersen,et al.  Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study , 2018, Gut.

[17]  Nima Hamidi,et al.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.

[18]  A. Ananthakrishnan,et al.  Systematic review with meta‐analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis , 2017, Alimentary pharmacology & therapeutics.

[19]  M. Zeegers,et al.  A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort—Can Diagnostic Factors Explain the Increase in IBD Incidence? , 2017, Journal of Crohn's & colitis.

[20]  Y. Jung,et al.  Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study , 2017, Journal of Crohn's & colitis.

[21]  Siddharth Singh,et al.  Natural History of Adult Ulcerative Colitis in Population‐based Cohorts: A Systematic Review , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  E. Loftus,et al.  Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010 , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  L. Peyrin-Biroulet,et al.  Crohn's disease , 2017, The Lancet.

[24]  M. Jiang,et al.  Sale of antibiotics without a prescription at community pharmacies in urban China: a multicentre cross-sectional survey , 2017, The Journal of antimicrobial chemotherapy.

[25]  Tzee‐Chung Wu,et al.  Gastrointestinal complications and extraintestinal manifestations of inflammatory bowel disease in Taiwan: A population‐based study , 2017, Journal of the Chinese Medical Association : JCMA.

[26]  J. Burisch,et al.  The incidence of inflammatory bowel disease in Denmark 1980–2013: a nationwide cohort study , 2017, Alimentary pharmacology & therapeutics.

[27]  M. Zeegers,et al.  Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort , 2017, The American Journal of Gastroenterology.

[28]  A. Rönnblom,et al.  Clinical course of Crohn’s disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005–2009* , 2017, Scandinavian journal of gastroenterology.

[29]  Xiao-Yong Wang,et al.  Association between physical activity and inflammatory bowel disease risk: A meta-analysis. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[30]  Wei-Chun Cheng,et al.  Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan , 2016, The American Journal of Gastroenterology.

[31]  C. Ponsioen,et al.  Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands , 2016, European journal of gastroenterology & hepatology.

[32]  S. Ng,et al.  Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong , 2016, Inflammatory bowel diseases.

[33]  A. Rönnblom,et al.  Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005–2009* , 2016, Scandinavian journal of gastroenterology.

[34]  A. Ananthakrishnan,et al.  Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis , 2016, Inflammatory bowel diseases.

[35]  R. Gearry,et al.  Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand , 2016, Inflammatory bowel diseases.

[36]  F. Clavel-Chapelon,et al.  Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study , 2016, Inflammatory bowel diseases.

[37]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[38]  Harjinder Singh,et al.  A first study on the incidence and prevalence of IBD in Malaysia--results from the Kinta Valley IBD Epidemiology Study. , 2015, Journal of Crohn's & colitis.

[39]  H. Ahn,et al.  Incidence and Natural Course of Inflammatory Bowel Disease in Korea, 2006–2012: A Nationwide Population-based Study , 2015, Inflammatory bowel diseases.

[40]  P. Munkholm,et al.  eHealth: Individualization of Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis , 2014, Inflammatory bowel diseases.

[41]  L. Kupčinskas,et al.  Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. , 2014, Journal of Crohn's & colitis.

[42]  A. Bitton,et al.  Epidemiology of Inflammatory Bowel Disease in Québec: Recent Trends , 2014, Inflammatory bowel diseases.

[43]  D. Manuel,et al.  Changing Age Demographics of Inflammatory Bowel Disease in Ontario, Canada: A Population-based Cohort Study of Epidemiology Trends , 2014, Inflammatory bowel diseases.

[44]  S. Ng,et al.  Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific , 2014, Gut.

[45]  A. Levy,et al.  Decreasing incidence of inflammatory bowel disease in Eastern Canada: a population database study , 2014, BMC Gastroenterology.

[46]  K. Yao,et al.  Second peak in the distribution of age at onset of ulcerative colitis in relation to smoking cessation , 2014, Journal of gastroenterology and hepatology.

[47]  Wei Wu,et al.  The Incidence of Inflammatory Bowel Disease in Northern China: A Prospective Population-Based Study , 2014, PloS one.

[48]  P. Munkholm,et al.  Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy , 2014, The American Journal of Gastroenterology.

[49]  A. Kasturiratne,et al.  Incidence of inflammatory bowel disease in Gampaha district: details of the Sri Lankan component of the Asia-Pacific Crohn's and colitis epidemiology study. , 2014, The Ceylon medical journal.

[50]  E. Horváth-Puhó,et al.  Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study , 2013, The American Journal of Gastroenterology.

[51]  H. Huhtala,et al.  The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. , 2013, Journal of Crohn's & colitis.

[52]  D. Spiegelman,et al.  Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses’ Health Study cohorts , 2013, BMJ.

[53]  W. Willett,et al.  A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. , 2013, Gastroenterology.

[54]  A. Zinsmeister,et al.  Cumulative Incidence and Risk Factors for Hospitalization and Surgery in a Population-based Cohort of Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[55]  S. Ng,et al.  First Prospective, Population-Based Inflammatory Bowel Disease Incidence Study in Mainland of China: The Emergence of “Western” Disease , 2013, Inflammatory bowel diseases.

[56]  S. Ng,et al.  Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. , 2013, Gastroenterology.

[57]  Y. Hao,et al.  Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: A prospective population‐based study , 2013, Journal of gastroenterology and hepatology.

[58]  P. Lakatos,et al.  The burden of inflammatory bowel disease in Europe. , 2013, Journal of Crohn's & colitis.

[59]  N. Pedersen,et al.  East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort , 2013, Gut.

[60]  P. Lakatos,et al.  Is Current Smoking Still an Important Environmental Factor in Inflammatory Bowel Diseases? Results from a Population-based Incident Cohort , 2013, Inflammatory bowel diseases.

[61]  M. Sears,et al.  Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months , 2013, Canadian Medical Association Journal.

[62]  Richard Hansen,et al.  Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis , 2012, The American Journal of Gastroenterology.

[63]  A. Zinsmeister,et al.  Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970–2004) , 2012, The American Journal of Gastroenterology.

[64]  L. Lakatos,et al.  Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006 , 2011, Inflammatory bowel diseases.

[65]  S. Ng,et al.  Genetics of inflammatory bowel disease in Asia: Systematic review and meta‐analysis , 2011, Inflammatory bowel diseases.

[66]  M. Frisch,et al.  Antibiotic use and inflammatory bowel diseases in childhood , 2010, Gut.

[67]  Yusuke Nakamura,et al.  A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population , 2009, Nature Genetics.

[68]  G. Kaplan,et al.  The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis , 2008, The American Journal of Gastroenterology.

[69]  S. Carding,et al.  Inflammatory bowel disease: cause and immunobiology , 2007, The Lancet.

[70]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[71]  Judy H. Cho,et al.  Defining Complex Contributions of NOD2/CARD15 Gene Mutations, Age at Onset, and Tobacco Use On Crohn's Disease Phenotypes , 2003, Inflammatory bowel diseases.

[72]  D. Chang,et al.  Epidemiology of inflammatory bowel disease in the Songpa‐Kangdong district, Seoul, Korea, 1986–2005: A KASID study , 2003, Inflammatory bowel diseases.

[73]  A. Ekbom,et al.  Appendectomy and protection against ulcerative colitis. , 2001, The New England journal of medicine.

[74]  R. Logan,et al.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). , 1996, Gut.

[75]  G. Savoye,et al.  Dramatic Increase in Incidence of Ulcerative Colitis and Crohn’s Disease (1988–2011): A Population-Based Study of French Adolescents , 2018, The American Journal of Gastroenterology.

[76]  S. Ng,et al.  Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. , 2016, Gastroenterology.

[77]  R. Malekzadeh,et al.  Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran. , 2016, Archives of Iranian medicine.

[78]  J. Frossard,et al.  Appendectomy and protection against ulcerative colitis. , 2001, The New England journal of medicine.

[79]  Anders Ekbom,et al.  Epidemiology of inflammatory bowel disease. , 1999, Nestle Nutrition workshop series. Clinical & performance programme.